Active Ingredient: BORTEZOMIB
(Hérité de BORTEZOMIB TEVA 3) (Hérité de BORTEZOMIB ARROW 3)
https://www.fda.gov/media/178811/download, https://doi.org/10.18632/oncotarget.25008